On July 30, 2026, Hester Biosciences Limited released its unaudited consolidated financial results for the quarter ending June 30, 2026, as per the exchange filings.
The company reported a total income of ₹78.89 crore and net profit of ₹96.73 crore for the quarter ending June 30, 2026.
In the June 2026 quarter, Hester Biosciences Limited's total income was ₹78.89 crore, down 8.7% from ₹86.42 crore in the corresponding quarter of the previous year.
The income also decreased by 18.7% from ₹97.08 crore in the March 2026 quarter.
Despite the decline in total income, the company achieved a net profit of ₹96.73 crore, which represents a 459.3% increase compared to ₹17.30 crore in the June 2025 quarter.
The net profit also rose by 484.6% from ₹16.55 crore in the March 2026 quarter.
For the financial year 2025-2026, Hester Biosciences Limited reported a total income of ₹342.28 crore. The net profit for the same period amounted to ₹57.48 crore. These figures provide a comprehensive view of the company's financial performance over the year.
The massive surge in consolidated profitability was primarily driven by a one-time exceptional accounting gain of ₹85.35 crore (INR 853.49 million) at Hester Africa. This gain arose from an amendment of the Gates Foundation loan, which was reduced from $12.0 million to $5.0 million.
Additionally, all accrued interest on this loan was waived, and the revised balance was modified to be interest-free.
Looking ahead into FY27, the company remains dedicated to its core strategy of "Building with Intent. Growing with Science". Hester plans to prioritize expansion in domestic and export market penetration while boosting its poultry and animal biological portfolios.
Capital will also be directed toward research and development for new products, regulatory submissions, and optimization of its newly commissioned manufacturing facilities.
Read More: Thangamayil Jewellery Share Price Falls Over 9% After Q1 FY27 Earnings Results: Total Income Up 71.2% YoY!
As of July 30, 2026, at 12:06 PM, Hester Biosciences share price on NSE was trading at ₹2,568.50, up by 2.87% from the previous closing price.
Hester Biosciences Limited's financial results for the June 2026 quarter show a decrease in total income to ₹78.89 crore, while net profit increased to ₹96.73 crore. The annual figures for FY26 indicate a total income of ₹342.28 crore and a net profit of ₹57.48 crore.
Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 30, 2026, 1:19 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
